EnvoyHealth, CMT Piloting Adherence Technology Program
FLINT, Mich. — July 28, 2017 — EnvoyHealth, a Diplomat company, partners with Compliance Meds Technologies to pilot medication adherence program.
EnvoyHealth, a Diplomat company, has partnered with Compliance Meds Technologies (CMT) to pilot a program for CleverCap LITE, a technology designed to improve patient medication adherence.
CMT strives to deliver innovative health technology solutions and services that help track and improve patients’ medication adherence.
CleverCap LITE offers medication monitoring and control for patients and providers. The compact, high-tech bottle cover:
- Records date and time of bottle access
- Records if a medication bottle isn’t properly reclosed
- Works with bottles or liquid vials
- Features visual and audio reminders, as well as a silent option
“One of the largest problems in health care is nonadherence to prescription medication,” said Jenny Cretu, senior vice president of pharma services and marketing. “Piloting technologies like CleverCap is key to long-term patient engagement and can help us understand crucial data and improve patient care and outcomes.”
According to the American Heart Association, medication nonadherence takes the lives of 125,000 Americans annually and costs the U.S. health care system nearly $300 billion per year in doctor visits, emergency department visits, and hospitalizations.
Not adhering to a medication regimen with respect to timing, dosage, and/or duration can interfere with a patient’s ability to treat and manage a disease, leading to a greater risk for complications and a lower quality of life.
“We are very excited about the partnership with Diplomat and EnvoyHealth,” said Moses Zonana, founder and CEO of CMT. “Our platform and engagement technology provides an ideal foundation for integrated medication management programs; our combined strengths set a new standard for outpatient medication management. With CMT, patients can be engaged when necessary, providing intelligent touchpoints and a better allocation of resources.”
To learn more about EnvoyHealth, visit envoyhealth.diplomat.is.
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events or our future financial or operating performance. The forward-looking statements contained in this press release are based on management’s good-faith belief and reasonable judgment based on current information. These statements are qualified by important risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from those forecasted or indicated by such forward-looking statements. For a discussion of such risks and uncertainties, you should review Diplomat’s filings with the Securities and Exchange Commission, including “Risk Factors” in Diplomat’s Annual Report on Form 10-K for the year ended Dec. 31, 2016, and in subsequent reports filed with or furnished to the Securities and Exchange Commission. Except as may be required by any applicable laws, Diplomat assumes no obligation to publicly update such forward-looking statements, which are made as of the date hereof or the earlier date specified herein, whether as a result of new information, future developments or otherwise.
Diplomat (NYSE: DPLO) is the nation’s largest independent provider of specialty pharmacy services—helping patients and providers in all 50 states. The company offers medication management programs for people with complex chronic diseases and delivers unique solutions for manufacturers, hospitals, payors, providers, and more. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information, visit diplomat.is.
About Compliance Meds Technologies (CMT)
CMT is a healthcare technology solutions provider with award-winning solutions designed to improve outcomes and mitigate financial risk by allowing providers to accurately track and manage medication utilization, and communicate in real-time with patients and caregivers. CMT solutions are intuitive, easy-to-use, cost-effective, and developed based upon the strategic needs and objectives of each client company. For more information, visit cmtcares.com.
Kali Lucas, Public Relations Specialist
810.768.9580 | email@example.com
Jenny Cretu, Senior Vice President,
Pharma Services and Marketing
810.768.9370 | firstname.lastname@example.org
@SpecialtyPTimesRT @SpecialtyPTimes: PBM Acquisition Allows @DiplomatRx to Expand Patient-Centric Offerings https://t.co/ntV4kEsnvX1 day ago
@DiplomatRxDiplomat Adds Chris Luthin as Executive Vice President https://t.co/JI0e9UIBHe1 day ago
@DiplomatRxDon’t forget to register for @CBI_Conferences “Patient Journey Mapping—From Diagnosis to Treatment.” This event gat… https://t.co/czVklVOW6Z2 days ago
@DiplomatRxDiplomat is at the #ASHP17 Midyear Clinical Meeting in Orlando. Come stop by our booth and say hello to Dwayne and… https://t.co/ImuUvX34C52 weeks ago
@CDCFluRT @CDCFlu: This National Influenza Vaccination Week, we’re highlighting the importance of flu vaccination and being a #FluFighter! https:/…2 weeks ago